IL6 and Alzheimer disease: We recently demonstrated the former in two different mouse models of AD, namely the 3xTg-AD mice and the Tg2576 mice, by crossing them with GFAP-sgp130Fc mice in order to obtain 3xTg-AD mice with the IL-6 trans-signaling pathway blocked in the CNS [26].